Literature DB >> 30339360

Nanoparticle-Mediated Acoustic Cavitation Enables High Intensity Focused Ultrasound Ablation Without Tissue Heating.

Adem Yildirim1, Dennis Shi1, Shambojit Roy1, Nicholas T Blum1, Rajarshi Chattaraj2, Jennifer N Cha1, Andrew P Goodwin1.   

Abstract

While thermal ablation of various solid tumors has been demonstrated using high intensity focused ultrasound (HIFU), the therapeutic outcomes of this technique are still unsatisfactory because of common recurrence of thermally ablated cancers and treatment side effects due to the high ultrasound intensity and acoustic pressure requirements. More precise ablation of tumors can be achieved by generating cavitating bubbles in the tissue using shorter pulses with higher acoustic pressures, which induce mechanical damage rather than thermal. However, it has remained as a challenge to safely deliver the acoustic pressures required for mechanical ablation of solid tumors. Here, we report a method to achieve mechanical ablation at lower acoustic pressures by utilizing phospholipid-stabilized hydrophobic mesoporous silica nanoparticles (PL-hMSN). The PL-hMSNs act as seeds for nucleation of cavitation events and thus significantly reduce the peak negative pressures and spatial-average temporal-average HIFU intensities needed to achieve mechanical ablation. Substantial mechanical damage was observed in the red blood cell or tumor spheroid containing tissue mimicking phantoms at PL-hMSN concentrations as low as 10 μg mL-1, after only 5 s of HIFU treatment with peak negative pressures ∼11 MPa and duty cycles ∼0.01%. Even the application of HIFU (peak negative pressure of 16.8 MPa and duty cycle of 0.017%) for 1 min in the presence of PL-hMSN (200 μg mL-1) did not cause any detectable temperature increase in tissue-mimicking phantoms. In addition, the mechanical effects of cavitation promoted by PL-hMSNs were observed up to 0.5 mm from the center of the cavitation events. This method may thus also improve delivery of therapeutics or nanoparticles to tumor environments with limited macromolecular transport.

Entities:  

Keywords:  cancer therapy; cavitation; high intensity focused ultrasound; mesoporous silica nanoparticles; tumor ablation

Mesh:

Substances:

Year:  2018        PMID: 30339360      PMCID: PMC6702128          DOI: 10.1021/acsami.8b15368

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  49 in total

Review 1.  High intensity focused ultrasound: surgery of the future?

Authors:  J E Kennedy; G R Ter Haar; D Cranston
Journal:  Br J Radiol       Date:  2003-09       Impact factor: 3.039

2.  Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity analysis.

Authors:  Andrea Ivascu; Manfred Kubbies
Journal:  J Biomol Screen       Date:  2006-09-14

3.  Controlled ultrasound tissue erosion: the role of dynamic interaction between insonation and microbubble activity.

Authors:  Zhen Xu; J Brian Fowlkes; Edward D Rothman; Albert M Levin; Charles A Cain
Journal:  J Acoust Soc Am       Date:  2005-01       Impact factor: 1.840

Review 4.  Image-guided tumor ablation: standardization of terminology and reporting criteria.

Authors:  S Nahum Goldberg; Clement J Grassi; John F Cardella; J William Charboneau; Gerald D Dodd; Damian E Dupuy; Debra Gervais; Alice R Gillams; Robert A Kane; Fred T Lee; Tito Livraghi; John McGahan; David A Phillips; Hyunchul Rhim; Stuart G Silverman
Journal:  Radiology       Date:  2005-04-21       Impact factor: 11.105

5.  Pulsed cavitational ultrasound therapy for controlled tissue homogenization.

Authors:  Jessica E Parsons; Charles A Cain; Gerald D Abrams; J Brian Fowlkes
Journal:  Ultrasound Med Biol       Date:  2006-01       Impact factor: 2.998

6.  Spatial variability in acoustic backscatter as an indicator of tissue homogenate production in pulsed cavitational ultrasound therapy.

Authors:  Jessica E Parsons; Charles A Cain; J Brian Fowlkes
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2007-03       Impact factor: 2.725

7.  Refining histotripsy: defining the parameter space for the creation of nonthermal lesions with high intensity, pulsed focused ultrasound of the in vitro kidney.

Authors:  Kathleen Kieran; Timothy L Hall; Jessica E Parsons; J Stuart Wolf; J Brian Fowlkes; Charles A Cain; William W Roberts
Journal:  J Urol       Date:  2007-06-15       Impact factor: 7.450

Review 8.  High-intensity focused ultrasound in the treatment of solid tumours.

Authors:  James E Kennedy
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

9.  The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population.

Authors:  R O Illing; J E Kennedy; F Wu; G R ter Haar; A S Protheroe; P J Friend; F V Gleeson; D W Cranston; R R Phillips; M R Middleton
Journal:  Br J Cancer       Date:  2005-10-17       Impact factor: 7.640

10.  A randomised clinical trial of high-intensity focused ultrasound ablation for the treatment of patients with localised breast cancer.

Authors:  F Wu; Z-B Wang; Y-De Cao; W-Z Chen; J Bai; J-Z Zou; H Zhu
Journal:  Br J Cancer       Date:  2003-12-15       Impact factor: 7.640

View more
  12 in total

1.  Phospholipid-Coated Hydrophobic Mesoporous Silica Nanoparticles Enhance Thrombectomy by High-Intensity Focused Ultrasound with Low Production of Embolism-Inducing Clot Debris.

Authors:  Nicholas T Blum; Ciara M Gyorkos; Spencer J Narowetz; Evan N Mueller; Andrew P Goodwin
Journal:  ACS Appl Mater Interfaces       Date:  2019-09-26       Impact factor: 9.229

2.  Temperature-Responsive Hydrophobic Silica Nanoparticle Ultrasound Contrast Agents Directed by Phospholipid Phase Behavior.

Authors:  Nicholas T Blum; Adem Yildirim; Ciara Gyorkos; Dennis Shi; Angela Cai; Rajarshi Chattaraj; Andrew P Goodwin
Journal:  ACS Appl Mater Interfaces       Date:  2019-04-23       Impact factor: 9.229

Review 3.  The role of anti-tumor immunity of focused ultrasound for the malignancies: depended on the different ablation categories.

Authors:  Luping Zhang; Chao Yang; Yixing Gao; Jinyun Chen; Wenzhi Chen
Journal:  Int J Clin Oncol       Date:  2022-08-09       Impact factor: 3.850

4.  Multifunctional Theranostic Nanoparticles for Enhanced Tumor Targeted Imaging and Synergistic FUS/Chemotherapy on Murine 4T1 Breast Cancer Cell.

Authors:  Zhengyue Kang; Min Yang; Xiaoling Feng; Hongjian Liao; Zhifei Zhang; Yonghong Du
Journal:  Int J Nanomedicine       Date:  2022-05-13

Review 5.  Nanotheranostics for Image-Guided Cancer Treatment.

Authors:  Isabel S Dennahy; Zheng Han; William M MacCuaig; Hunter M Chalfant; Anna Condacse; Jordan M Hagood; Juan C Claros-Sorto; Wajeeha Razaq; Jennifer Holter-Chakrabarty; Ronald Squires; Barish H Edil; Ajay Jain; Lacey R McNally
Journal:  Pharmaceutics       Date:  2022-04-22       Impact factor: 6.525

6.  Targeted and pH-facilitated theranostic of orthotopic gastric cancer via phase-transformation doxorubicin-encapsulated nanoparticles enhanced by low-intensity focused ultrasound (LIFU) with reduced side effect.

Authors:  Zhangluxi Liu; Haitao Ran; Zhigang Wang; Shiji Zhou; Yaxu Wang
Journal:  Int J Nanomedicine       Date:  2019-09-18

Review 7.  Colloids, nanoparticles, and materials for imaging, delivery, ablation, and theranostics by focused ultrasound (FUS).

Authors:  Adem Yildirim; Nicholas T Blum; Andrew P Goodwin
Journal:  Theranostics       Date:  2019-04-13       Impact factor: 11.556

Review 8.  Review on Acoustic Droplet Vaporization in Ultrasound Diagnostics and Therapeutics.

Authors:  Ksenia Loskutova; Dmitry Grishenkov; Morteza Ghorbani
Journal:  Biomed Res Int       Date:  2019-07-14       Impact factor: 3.411

Review 9.  MRI-traceable theranostic nanoparticles for targeted cancer treatment.

Authors:  Tareq Anani; Shiva Rahmati; Nayer Sultana; Allan E David
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 10.  Gas-stabilizing nanoparticles for ultrasound imaging and therapy of cancer.

Authors:  Sinan Sabuncu; Adem Yildirim
Journal:  Nano Converg       Date:  2021-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.